Target antigens for Hs-14 monoclonal antibody and their various expression in normozoospermic and asthenozoospermic men
© Capkova et al. 2015
Received: 10 June 2015
Accepted: 22 October 2015
Published: 6 November 2015
Poor semen quality is one of the main causes of infertility. We have generated a set of monoclonal antibodies to human sperm and used them to investigate sperm quality. Some of these antibodies found differences in the expression of proteins between normal sperm and pathological sperm displaying severe defects. One of them was the Hs-14 antibody.
The aim of this paper was to determine the target protein of the Hs-14 monoclonal antibody and to investigate the expression of the Hs-14-reacting protein on the sperm of asthenozoospermic men with sperm motility defect and of healthy normozoospermic men.
Indirect immunofluorescence, one-dimensional and two-dimensional polyacrylamide gel electrophoresis, immunoblotting and mass spectrometry.
The Hs-14 antibody binds fibronectin, β-tubulin and valosin-containing protein - new name for this protein is transitional endoplasmic reticulum ATPase (TERA). Since the Hs-14 reaction with TERA remained the strongest at the highest antibody dilution, and Hs-14 consistently labelled the same spot or band as the monospecific anti-TERA antibody on immunoblots, we assume that TERA is an Hs-14-specific protein. Binding of fibronectin and β-tubulin might represent nonspecific cross-reactivity or Hs-14 reaction with similar epitopes of these proteins.
A significant difference (P < 0.001) in immunofluorescence staining with Hs-14 was found between the normozoospermic and asthenozoospermic men.
The Hs-14 antibody enables discrimination between sterile or subfertile asthenozoospermic and fertile normozoospermic men. Decreased levels of TERA in men can be used as a biomarker of reduced fertility.
La pauvre qualité de la semence est l’une des causes d’infertilité. Nous avons généré une série d’anticorps monoclonaux contre le sperme humain et nous l’avons utilisée pour examiner la qualité du sperme. Certains de ces anticorps ont montré des différences d’ expression des protéines entre le sperme normal et le sperme pathologique qui a des défauts sévères. L’un d’eux a été l’anticorps Hs-14. Le but de cet article était de déterminer la protéine cible de l’anticorps monoclonal Hs-14 et d’établir l’expression de la protéine réagissant avec Hs-14 sur le sperme des hommes asthénozoospermiques qui ont des défauts de la mobilité du sperme et sur celui des hommes normozoospermiques.
Immunofluorescence indirecte, electrophorèse sur gel polyacrylamide à une ou deux dimensions, immunoblotting et spectrométrie de masse.
L’anticorps Hs-14 s’attache à la fibronectine, à la β-tubuline et à la protéine TERA (ATPase transitoire de réticulum endoplasmique). Etant donné que la réaction du Hs-14 avec TERA a été la plus forte à la dilution la plus grande de l’anticorps, et que Hs-14 marquait systématiquement la même tache ou bande que l’anticorps mono-spécifique anti-TERA sur les immunoblots, nous supposons que TERA est une protéine spécifique pour Hs-14. L’attachement à la fibronectine et à la β-tubuline pourrait représenter une réaction croisée non spécifique ou la réaction du Hs-14 avec des épitopes similaires de ces protéines. Une différence significative (P < 0.001) en immunofluorescence avec Hs-14 a été révélée entre hommes normozoospermiques et asthénozoospermiques.
L’anticorps Hs-14 permet de différencier les hommes stériles ou subfertiles asthénozoospermiques des hommes fertiles normozoospermiques. Les niveaux de la TERA chez les hommes pourraient être utilisés comme un marqueur biologique d’une fertilité réduite.
Antibodies to human sperm proteins and seminal plasma proved to be useful tools for the sperm quality assessment, and consequently for the prognosis of successful fertilization of eggs. In IVF clinics, semen quality is routinely assessed by the concentration, morphology and motility of spermatozoa, as it is given in WHO guidelines . Nevertheless, to better understand the fertility problems, more complex analysis of the expression of individual proteins and their function in the sperm processes, e,g. changes of individual proteins during the acrosomal reaction, capacitation and other processes, is needed [2–7].
Employment of antibodies thus elevated evaluation of sperm ejaculates to the level of investigation of individual proteins relevant for the sperm function. Using the set of monoclonal antibodies that we generated in our laboratory we were able to perform a systematic and continuous analysis of ejaculates for the needs of assisted reproduction. These antibodies can detect poor quality sperm samples even in cases when the parameters of ejaculates meet the requirements of WHO classification for normozoospermics. For example, our antibodies Hs-8, Hs-14 and Hs-36 reliably bound to the acrosomes of spermatozoa in normozoospermic men (60–80 % cells labelled), while their binding was lower in ejaculates with pathological spermiograms (30–40 % cells labelled) . The ability of our anti-acrosomal antibodies to recognize defective spermatozoa was confirmed by assessment of sperm in the mice that were exposed to pollutants [9, 10]. Both findings undoubtedly suggest the importance of the detected proteins in fertilization. The condition when a semen sample complies with the WHO requirements and still is not able to achieve fertilization is not exceptional. In some cases, the expression of certain proteins is altered compared to normal sperm  and antibodies represent an appropriate tool to detect the changes in the expression of specific proteins . However, the sperm quality assessment cannot be based on a single protein. Our experience with the Hs-16 monoclonal antibody that detects secretory actin-binding protein (SABP)  demonstrated that some normozoospermic samples might display high expression of SABP, whose presence on spermatozoa is associated with sperm pathology . It is obvious that sperm testing must be comprehensive—optimally using a panel of antibodies.
Recently, great possibilities in this respect have been offered by proteomics, where two-dimensional gels enable simultaneous evaluation of hundreds of proteins and provide a complex picture of the investigated sample [14–16].
Comparison between 2D electrophoretic gels of normal and pathological sperm allowed us to select proteins or groups of proteins whose changes in the expression can be a signal of pathological condition [17, 18].
Employment of monoclonal antibodies as a diagnostic tool is dependent on the definition of antibody specificity. The aim of our work was to characterize the Hs-14 monoclonal antibody, i.e., to investigate its target protein and binding in normozoospermic and asthenozoospermic men.
Human ejaculates were obtained with the participants’ consent from the Centre of assisted reproduction ISCARE I.V.F. (Prague, Czech Republic). All men (of age 25–40 years) gave their written informed consent with donating the sperm ejaculates for the purposes of the research project. The study was also approved by the institutional review board at the Institute of Biotechnology. Thirty sperm samples from men with normal spermiograms and 30 samples from men with asthenozoospermia with reduced motility (<40 %) were assessed. The evaluation of semen density, motility and morphology was carried out in compliance with the World Health Organization standards (2010) .
Sperm sample from each men was independently repeated three times. The results were comparable and therefore one of them was chosen for presentation.
Preparation of Hs-14 monoclonal antibody
The Hs-14 monoclonal antibody (mAb) was generated by standard hybridoma technology introduced to the laboratory by Peknicova et al. , after immunization of BALB/c mice with the acid extract of human sperm and fusion with SP2/0-Ag14 myeloma cells (Sigma, Prague, Czech Republic). The acid extract was prepared from the ejaculate of a normozoospermic donor (6 × 107 cells/ml, 60 % motility) as follows: the ejaculate was centrifuged at 200 × g and the sperm pellet was resuspended and washed three times in phosphate-buffered saline (PBS, 150 mM NaCl, 17.7 mM NaH2(PO4).2H2O, pH 7.4). The cell pellet was then extracted in 3 % (v/v) acetic acid, 10 % (v/v) glycerol, 30 mM benzamidine for 16 h after cooling at 4 °C with permanent rotation. The extract was dialyzed against 0.2 % acetic acid and lyophilized.
Positive clones were selected by enzyme-linked immunosorbent assay (ELISA)  and indirect immunofluorescence test [13, 21]. The Mouse Monoclonal Antibody Isotyping Reagents (ISO-2, Sigma, Prague, Czech Republic) were used to determine the immunoglobulin class of the monoclonal antibody according to the manufacturer’s instructions.
Besides the Hs-14 monoclonal antibody the following antibodies were used: Prog.13 against progesterone (mouse IgG) prepared in our laboratory , TU-06 against the N-terminal domain of β-tubulin (mouse IgM) , TU-01 against the N-terminal domain of α-tubulin (mouse IgG1)  and ab11433 against valosin-containing protein (transitional endoplasmic reticulum ATPase), (mouse IgG, Abcam, UK).
Microtubule protein from porcine brain was prepared according to Shelanski et al. . The entire procedure of tubulin preparation was described in detail by Draber et al. . For preparation of the gel and sodium dodecyl sulphate (SDS) sample of tubulin we used SDS cat.no. L5750 (Sigma, Prague, Czech Republic), which makes possible better separation of α- and β-tubulin.
Indirect immunofluorescence was carried out with human spermatozoa. Samples were washed twice with PBS and centrifuged at 200 × g for 10 min. Washed cells were diluted in PBS to a final concentration of 2 × 107 cells/ml and 10 μl drops were smeared onto glass slides. Alternatively, spermatozoa were diluted to a final concentration of 1 × 106 /ml and 10 μl drops were loaded on glass slides. Smears or drops were air-dried and then fixed and permeabilized with acetone for 10 min at room temperature (RT, 23 °C). Slides were rinsed in PBS, blocked in PBS-0.05%Tween + 1 % bovine serum albumin + 10 % normal goat serum for 3 h at RT and incubated in a humid chamber with the Hs-14 mAb (undiluted hybridoma supernatant, immunoglobulin concentration <20 μg/ ml) for 60 min at 37 ° C. As a negative control, undiluted supernatant of Sp2/0 myeloma cells was used. After three washes in PBS the slides were incubated with fluorescein isothiocyanate (FITC)-conjugated goat anti-mouse IgM (μ − chain specific) immunoglobulin (Sigma, Prague, Czech Republic) diluted 1:128 in PBS for 1 h at 37 °C. Then the slides were washed in PBS, rinsed in deionized water, quickly air-dried, dropped with mounting medium Vectashield containing DAPI for DNA visualization (Vector Laboratories, Burlingame, CA, USA) and covered with a cover glass. Slides were stored at +4 °C until inspection. In immunofluorescent test 200 cells were evaluated for each sample and each sample was repeated 3 times.
Samples were examined with a Nikon Eclipse E400 fluorescent microscope with Nikon Plan Apo VC oil 60× objective and photographed with CCD camera VDS1300 (Vosskühler, Osnabrück, Germany) with the aid of the NIS elements AR imaging software (Laboratory Imaging, Prague, Czech Republic). Some immunofluorescent samples were also examined with confocal microscope Olympus FV-1000, where digitized images of serial optical 3 μm-thick sections of spermatozoa were collected.
Electrophoresis, western blotting and immunodetection
Unless otherwise indicated, all chemicals for sample preparation, electrophoresis, blotting and immunodetection were purchased from Sigma (Prague, Czech Republic).
In all electrophoretic experiments, samples from normal sperm were used. Ejaculated spermatozoa were washed three times in PBS and used for protein extraction. For one-dimensional polyacrylamide gel electrophoresis (1D PAGE), a dry sperm pellet (1 × 108 cells) was resuspended in 100 μl of non-reducing 2× SDS sample buffer  and heated in boiling water bath (3 min). After cooling in + 4 °C and centrifugation (23,100 × g, 5 min, 4 °C), the supernatant was divided into aliquots and kept at -80 °C until electrophoresis. To observe the migration of proteins under reducing conditions, samples were supplemented with β − mercaptoethanol (5 % final concentration) and heated for 1 min in boiling water bath prior to electrophoresis.
Sperm cells (1× 108) were resuspended in 100 μl of rehydration buffer (RHB, 7 M urea, 2 M thiourea, 4 % CHAPS, 1 % Triton X-100, 20 mM Tris) or 1 % Triton X-100.
For two-dimensional gel electrophoresis (2D PAGE), sperm cells (1 × 108 cells) were resuspended in 100 μl of RHB and extracted for 1 h at room temperature with occasional shaking. Then the samples were centrifuged (23,100 × g, 5 min, RT), and supernatants were aliquoted and stored at −80 °C for subsequent analysis.
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS PAGE) and Western Blotting (WB)
Polyacrylamide gel electrophoresis in the presence of SDS (SDS PAGE) was performed according to the method of Laemmli . Aliquots of non-reduced or reduced extracts corresponding to 10 μg of protein content were loaded per lane. Proteins were separated in 12 % polyacrylamide gel and visualized by Coomassie Brilliant Blue (CBB-R250, Serva, Heidelberg, Germany) staining or electrophoretically transferred onto PVDF membrane (Immobilon-P Transfer Membrane, Millipore, Bedford, USA), essentially according to the method of Towbin et al. . Molecular masses of the proteins were estimated by comparison with the Precision Plus Protein Standard Dual colour (BioRad, Prague, Czech Republic) running in parallel.
All chemicals, solutions, strips and Ettan IPGphor system for electrophoretic protein separation in the first dimension were purchased from GE Healthcare (Uppsala, Sweden).
The sperm sample, 150 μg (for pH range 3–10) or 200 μg (for pH range 4–7) of protein in total volume of 180 μl of RHB freshly supplemented with 1 % (w/v) dithiotreitol and 2 % (v/v) IPG buffer (pH 3–10, Amersham Biosciences, Uppsala, Sweden), was applied to a 7 cm long strip (Immobiline Drystrip) and passively rehydrated overnight at RT. Proteins were focused for approx. 5 h with 50 mA per strip as follows: 150 V for 50 min, 150–300 V for 1 h (gradient), 300–1000 V for 30 min (gradient), 1000 V for 20 min, 1000–5000 V for 1 h and 20 min (gradient), 5000 V as long as 8000 Vh in total were achieved.
After focusing the strips were incubated in equilibration buffer (EB, 6 M urea, 50 mM Tris–HCl buffer pH 6.8, 30 % (v/v) glycerol, 2 % (w/v) SDS, 0.002 % w/v bromophenol blue), containing 2 % (w/v) dithiotreitol for 15 min and with 1 % (w/v) iodoacetamide in EB for 15 min. Strips were laid onto a 12 % polyacrylamide slab gel for the second-dimension electrophoresis (2D PAGE).
Blots with an identical set of proteins were incubated in PBST solution (0.05 % Tween 20 (v/v) in PBS) supplemented with 3 % gelatin overnight at 4 ° C and afterwards incubated separately for 1 h at RT with undiluted or PBST-diluted hybridoma supernatants (1:1). As a control, the supernatant of Sp2/0 cells (null supernatant) was used. After six 10-min washes in PBST, horseradish peroxidase (HRP)-conjugated goat anti- mouse antibody (GAM/Px, diluted 1:3000, BioRad, Prague, Czech Republic) was applied for 1 h at RT. After that the blots were again intensively washed (1 h, 10 PBST exchanges) and the reaction of antibodies (the corresponding protein bands or spots) was developed with SuperSignal West Pico chemiluminescent substrate (Pierce, Rockford, USA).
Alternatively, the membrane was developed in the dark at room temperature with 0.05 % (w/v) 4-chloro-1-naphtol (Serva, Heidelberg, Germany), 0.001 % (w/v) CoCl2 and 0.09 % (v/v) hydrogen peroxide in 0.01 M Tris–HCl (pH 7.4). The reaction was stopped after 10 min by washing the membrane in distilled water.
Relative molecular masses of proteins detected by monoclonal antibodies were estimated by comparison with the mobility of molecular mass protein standards running in parallel after staining of blots with Coomassie Brilliant Blue (0.25 % CBB R250, 7 % CH3COOH, 50 % ethanol).
Mass spectrometric analysis
Gels intended to mass spectrometry were incubated for 1 h at room temperature in a solution containing CBB-R250, and in the solution of 35 % ethanol, 10 % CH3COOH until the background disappeared and the separated proteins in 2D PAGE were clearly and sharply visible.
Sample preparation and proteolytic digestion
All chemicals for sample preparation and mass spectrometric analysis were purchased from Sigma-Aldrich (St Louis, MO, USA).
CBB-R250-stained protein spots of interest were excised from the gel and decolorized several times in sonic bath at 60 °C with 10 mM dithiothreitol, 0.1 M 4-ethylmorpholine acetate (pH 8.1) in 50 % acetonitrile (ACN) until complete destaining. Then the gel was washed with water, shrunk by dehydration with ACN and reswollen by incubation in 60 mM iodoacetamide, 0.1 M 4-ethylmorpholine acetate (pH 8.1) for half an hour in the dark at RT. After cysteine alkylation, the gel was washed with water, shrunk by dehydration with ACN and reswollen in water. The rehydration and dehydration of the gel was repeated three times. Next, the gel was reswollen in 0.05 M 4-ethylmorpholine acetate (pH 8.1) in 50 % ACN and partly dried using a SpeedVac concentrator (Savant, Holbrook, NY, USA). Finally, the gel was reconstituted with cleavage buffer containing 0.01 % 2-mercaptoethanol, 0.05 M 4-ethylmorpholine acetate, 10 % ACN, and sequencing grade trypsin (Promega, 50 ng/μl). Digestion was carried out overnight at 37 °C, and the resulting peptides were extracted with 30 % ACN/0.1 % trifluoroacetic acid and subjected to mass spectrometric analysis.
MALDI/FT-ICR MS (Matrix Assisted Laser Desorption/Ionization Fourier Transformed Ion Cyclotron Resonance Mass Spectrometry)
Masses of individual peptides obtained after tryptic digestion of Hs-14-detected protein(s) were determined by the peptide mass fingerprint. Mass spectra of peptides were measured using a MALDI/FT-ICR mass spectrometer (9.4 T APEX-Qe, Dual ion source II, Bruker Daltonics, Billarica, U.S.A.), a peptide map(s) was (were) established, and mass spectra were searched against the human Swissprot database using Mascot 2.3 software (Matrix Science). The spectrum was calibrated internally using the monoisotopic [M + H]+ ions of trypsin autoproteolytic products. A saturated solution of α-cyano-4-hydroxy-cinnamic acid in 50 % ACN/0.2 % TFA was used as a MALDI matrix. One μl of matrix solution was mixed with 1 μl of the sample on the target and the droplet was allowed to dry at ambient temperature. The mass accuracy was set to less than 3 ppm for the data interpretation.
Experimental data were analysed using GraphPad Prism 5.04. The differences between the normozoospermic and asthenozoospermic group in the number of Hs-14-positive cells were analysed by two-tailed Mann Whitney test. The p value equal to or lower than 0.05 was considered to be significant, *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 0.001.
Hs-14 monoclonal antibody
By fusion of immune spleen cells with Sp2/0 myeloma cells we obtained 80 independently derived clones. One of the positive clones, D5A12, generated the hybridoma producing monoclonal antibody designated Hs-14. Analysis of immunoglobulin class showed that the Hs-14 antibody belongs to IgM molecules.
Immunofluorescent localization of the antigen recognized by the Hs-14 mAb
Western blot analysis of human sperm protein(s) detected by the Hs-14 mAb
Identification of the Hs-14-corresponding proteins by MALDI mass spectrometry
Comparison of anti-TERA and Hs-14 reaction with human sperm extract
Reaction of Hs-14 and anti-tubulin mAbs with purified tubulin
Immunodetection of the human sperm proteins with diluted Hs-14 mAb
Expression of the Hs-14-reacting protein(s) in the sperm of normozoospermic and asthenozoospermic men
Discussion and conclusion
The Hs-14 monoclonal antibody was proved successful in the assessment of human semen quality [8, 9]. A significant positive correlation was found between the Hs-14-detected protein(s) on the sperm and the semen quality.
To characterize the antibody we applied indirect immunofluorescence, biochemical methods and mass spectroscopy. Further, using the Hs-14 antibody we investigated the relevant proteins on the sperm from men with normozoospermia and asthenozoospermia.
Based on our results, we can conclude that the Hs-14 monoclonal antibody is not monospecific but binds several proteins or similar epitopes of these proteins. After one-dimensional electrophoresis, the antibody recognized four protein bands of about 240, 110, 95 and 50 kDa on the immunoblot. After sperm sample separation in two-dimensional electrophoresis, two protein spots reacting with the Hs-14 mAb were found on the blot. Molecular masses of these spots were about 95 and 55 kDa, and mass spectrometric analysis identified these proteins as transitional endoplasmic reticulum ATPase (TERA) and tubulin, respectively. These results were obtained repeatedly with different samples. The two remaining proteins—of 240 and 110 kDa—were not identified on the gel after 2D electrophoresis. One of these proteins, of 240 kDa, was extracted from the gel after 1D electrophoresis and sequenced, and was identified as a fibronectin precursor. Nevertheless, protein sequencing from the 1D gel has limitations.
The participation of these three proteins in fertility has already been investigated and their role was found to be highly significant.
Fibronectin (Fn) is an adhesive molecule that binds to β1, 3 and 4 integrins on the sperm surface  and immunofluorescence revealed a broad distribution pattern of Fn on the sperm heads . In human sperm, Fn has various functions: it activates the proteasome and induces the acrosomal reaction , participates in the sperm-egg interaction , and increased Fn concentration is associated with decreased sperm motility and thus with fertility problems in men [33, 34].
Tubulin is the main structural element of the cell cytoskeleton. In mature spermatozoon tubulin is localized in two major compartments: flagellum and head [26, 35, 36]. The flagellum is composed of a typical arrangement of microtubules and is the organ of sperm motility , which is closely related to sperm fertility. Our previous study revealed differences in the amount of β-tubulin among men with normozoospermia and pathological spermiograms .
Transitional endoplasmic reticulum ATPase (TERA) is a glycoprotein that is involved in membrane fusion and presentation of ubiquitinated proteins to the proteasome . TERA is found in the sperm of different species and is a substrate of cAMP-activated sperm tyrosine kinase . In human sperm TERA is one of the proteins that are phosphorylated during capacitation . Recently, TERA was identified as one of the targets of post-translational modification, sumoylation in the sperm . Sumoylation gives rise to small ubiquitin-like modifiers (SUMO) that are implicated in the regulation of numerous cellular events and also in the maturation and differentiation of sperm .
Thus, each of these proteins can affect the sperm ability to fertilize eggs. We tried to find whether Hs-14 specifically recognizes all the three proteins that were identified by mass spectrometry and is polyspecific or whether the Hs-14 reactivity is partially caused by non-specific cross-reactivity or the reaction with similar epitopes of these proteins. Some characteristics of the relevant proteins indirectly exclude specific reaction with the Hs-14 antibody. The concentration of fibronectin on the sperm surface is negatively correlated with the sperm motility [33, 34], while the number of spermatozoa labelled with Hs-14 is positively correlated with the sperm quality. Immunofluorescent examination of spermatozoa by confocal microscopy also demonstrated intracellular localization of the target protein, while fibronectin is a spermadhesive protein.
The mass spectrometry determination of tubulin recognition by Hs-14 was verified by direct reaction of Hs-14 with purified tubulin on Western blot and β − tubulin was confirmed as one of the Hs-14-reacting proteins. However, in immunofluorescence the antibody labelled the flagellum, where tubulin is located, less often than in the acrosome or not at all. This knowledge also supports non-specific Hs-14 reaction with tubulin.
The Hs-14 specificity was also investigated after its dilution. At 500× dilution, the antibody reacted considerably more strongly with TERA than with β-tubulin and fibronectin. This reaction indicated TERA as the most probable Hs-14-specific protein, while Hs-14 reaction with β-tubulin and fibronectin suggested nonspecific cross-reactivity.
In addition, the reaction of monoclonal anti-TERA and Hs-14 antibodies with various independently prepared sperm extracts indicates TERA as the Hs-14 specific protein. Both antibodies consistently labelled the same band of about 95 kDa on Western blots. Only in the case of the strongest sperm extract (Fig. 7) Hs-14 labelled additional bands.
We also wanted to identify the Hs-14 target protein by immunoprecipitation of human sperm lysate with the Hs-14 antibody. For the experiment we used a direct immunoprecipitation kit (Pierce Protein Biology product) according to the manufacturer’s instructions, in which the relevant antibody (Hs-14) was covalently bound to aldehyde-activated beaded agarose resin and sperm protein lysate was added. Unfortunately, we did not obtain an unequivocal result. The following electrophoresis did not determine one protein only and it also supported Hs-14 nonspecific cross-reactivity with several proteins. Similar results were obtained by a classical immunoprecipitation test with protein A.
The other reason for the difficulty in unequivocally identifying the Hs-14 target protein can be the complex IgM nature of the Hs-14 antibody. IgM antibodies are frequently associated with unspecific cross-reactivity, and therefore are generally less reliable.
As mentioned above, the basic aim of this study was to identify the Hs-14-recognized protein(s), because the antibody proved to be a good marker for sperm quality evaluation . In our previous investigations we followed the differences among normozoospermic and pathological sperm mainly with severe damage. Here we utilized the antibody and concentrated on the differences between normozoospermic and asthenozoospermic men found by the Hs-14 antibody. Spermatozoa of asthenozoospermic men are seemingly of good quality, with normal morphology, and the sperm concentration in asthenozoospermic ejaculates is also normal (>15 × 106 cells per ml) . The only apparent defect is their decreased motility. Still, many asthenozoospermic patients are sterile or subfertile and this deficiency can be circumvented by in vitro fertilization using intracytoplasmic sperm injection.
Monitoring of asthenozoospermic and normozoospermic samples showed decreased Hs-14 protein expression in 15 out of 30 asthenozoospermic men (<60 % labelled cells), while only three out of 30 followed normozoospermic individuals displayed less than 60 % labelled cells. Statistical analysis showed a significant difference (P < 0.001) in the number of Hs-14- positive spermatozoa between both groups.
Our data showed decreased expression of relevant sperm protein TERA (formerly VCP) in asthenozoospermic men. Recently, TERA was identified as a protein playing a role in ubiquitination . Decreased detection of this protein in asthenozoospermic men can most probably be explained by spontaneous acrosome reaction, which may occur in ejaculated sperm or impaired synthesis of the protein in the sperm with pathological spermiograms.
Our data suggest transitional endoplasmic reticulum ATPase (TERA - formerly VCP) as target protein of Hs-14 monoclonal antibody and revealed decreased expression of TERA in asthenozoospermic men in comparison with normozoospermic ones. We can conclude that appropriate monoclonal antibodies against sperm can be used not only as biomarkers of sperm quality, but also for detection of sperm defects at the molecular level.
Authors thank Dr. Olina Tepla for sperm samples of men from the IVF Center, Dr. Andryi Dorosh and Dr. Pavla Postlerova for critical reading of the manuscript, Mgr. Lukas Ded for his help with statistical analysis and Dr. Sarka Takacova for English corrections. This work was supported by the Grant Agency of the Czech Republic (No. GAP503/12/1834), and by BIOCEV project from the ERDF (CZ.1.05/1.1.00/02.0109) to JC, JP, HM, AK and Charles University (project UNCE 204025/2012) to PN. Access to instruments and other facilities was supported by the EU (Operational Program Prague – Competitiveness project CZ.216/3.1.00/24023).
Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
- WHO. WHO laboratory manual for the examination of human semen and semen-cervical mucus interaction. 5th ed. Cambridge: Cambridge University Press; 2010.Google Scholar
- Reddy KV, Meherji PK, Shahani SK. Integrin cell adhesion molecules on human spermatozoa. Indian J Exp Biol. 1998;36(5):456–63.PubMedGoogle Scholar
- Gadkar S, Shah CA, Sachdeva G, Samant U, Puri CP. Progesterone receptor as anindicator of sperm function. Biol Reprod. 2002;67(4):1327–36.View ArticlePubMedGoogle Scholar
- Nasr-Esfahani MH, Salehi M, Razavi S, Mardani M, Bahramian H, Steger K, et al. Effect of protamine-2 deficiency on ICSI outcome. Reprod Biol Online. 2004;9(6):652–8.View ArticleGoogle Scholar
- Tepla O, Peknicova J, Koci K, Mika J, Mrazek M, Elzeinova F. Evaluation of reproductive potencial after intracytoplasmic sperm injection of varied human semen tested by antiacrosomal antibodies. Fertil Steril. 2006;86(1):113–20.View ArticlePubMedGoogle Scholar
- Anahí Franchi N, Avedano C, Molina RI, Tissera AD, Maldonado CA, Oehninger S, et al. Beta-Microseminoprotein in human spermatozoa and its potential role in male fertility. Reproduction. 2008;136(2):157–66.View ArticlePubMedGoogle Scholar
- Sutovsky P, Lovercamp K. Molecular markers of sperm quality. Soc Reprod Fertil Suppl. 2010;67:247–56.PubMedGoogle Scholar
- Peknicova J, Chladek D, Hozak P. Monoclonal antibodies against sperm intra- acrosomal antigens as markers for male infertility diagnostics and estimation of spermatogenesis. Am J Reprod Immunol. 2005;53:42–9.View ArticlePubMedGoogle Scholar
- Peknicova J, Kyselova V, Buckiova D, Boubelik M. Effect of an endocrine disruptor on mammalian fertility. Application of monoclonal antibodies against sperm proteins as markers for testing sperm damage. AJRI. 2002;47:311–8.PubMedGoogle Scholar
- Kyselova V, Peknicova J, Boubelik M, Buckiova D. Body and organ weight, sperm acrosomal status and reproduction after genistein and diethylstibestrol treatment of CD1 mice in multigenerational study. Theriogenology. 2004;61:1307–25.View ArticlePubMedGoogle Scholar
- Pixton KL, Deeks ED, Flesch FM, Moseley FLC, Bjorndahl L, Ashton R, et al. Sperm proteome mapping of a patient who experienced failed fertilization at IVF reveals altered expression of at least 20 proteins compared with fertile donors: case report. Hum Reprod. 2004;19(6):1438–47.View ArticlePubMedGoogle Scholar
- Shimizu Y, Kodama H, Fukuda J, Tanaka T. Evidence of proacrosine molecule abnormality as a possible cause of low acrosin activity and unexplained failure of fertilization in vitro. J Androl. 1997;18(3):281–8.PubMedGoogle Scholar
- Capkova J, Elzeinova F, Novak P. Increased expression of secretory actin-binding protein on human spermatozoa is associated with poor semen quality. Hum Reprod. 2007;22(5):1396–404.View ArticlePubMedGoogle Scholar
- Oliva R, Martínez-Heredia J, Estanyol JM. Proteomics in the study of the sperm cell composition, differentiation and function. Syst Biol Reprod Med. 2008;54(1):23–36.View ArticlePubMedGoogle Scholar
- duPlessis SS, Kashou AH, Benjamin DJ, Yadav SP, Agarval A. Proteomics: a subcellular look at spermatozoa. Reprod Biol Endocrinol. 2011;9:36.View ArticleGoogle Scholar
- Baker MA, Nixon B, Naumovski N, Aitken RJ. Proteomic insights into the maturation and capacitation of mammalian spermatozoa. Syst Biol Reprod Med. 2012;58(4):211–7.View ArticlePubMedGoogle Scholar
- Liao TT, Xiang Z, Zhu WB, Fan LQ. Proteome analysis of round-headed and normal spermatozoa by 2-D fluorescence difference gel electophoresis and mass spectrometry. Asian J Androl. 2009;11(6):638–93.View ArticleGoogle Scholar
- Thacker S, Yadav SP, Sharma RK, Kashou A, Williard B, Zhang D, et al. Evaluation of sperm proteins in infertile men: a proteomic approach. Fertil Steril. 2011;95(8):2745–8.View ArticlePubMedGoogle Scholar
- Peknicova J, Capkova J, Cechova D, Sulcova B. Preparation and characterization of a monoclonal antibody against boar acrosin. Folia Biol (Praha). 1986;32:282–5.Google Scholar
- Koubek P, Elzeinova F, Sulc M, Linhart O, Peknicova J. Monoclonal antibody FsC-47 against carp sperm creatine kinase. Hybridoma. 2006;25(3):154–7.View ArticlePubMedGoogle Scholar
- Peknicova J, Moos J. Monoclonal antibodies against sperm intra-acrosomal antigens labelling undamaged acrosomes of spermatozoa in immunofluorescence test. Andrologia. 1990;22(5):427–35.View ArticlePubMedGoogle Scholar
- Moos J, Peknicova J. Monoclonal antibodies against progesterone. Am J Reprod Med. 1988;16:88.Google Scholar
- Dráber P, Dráberová E, Linhartová I, Viklický V. Differences in the exposure of C-and N- terminal tubulin domains in cytoplasmic microtubules detected with domain-specific monoclonal antibodies. J Cell Sci. 1989;92:519–28.PubMedGoogle Scholar
- Grimm E, Breitling F, Little M. Location of the epitope for the alpha-tubulin monoclonal antibody TU-01. Biochim Biophys Acta. 1987;914:83–8.View ArticlePubMedGoogle Scholar
- Shelanski ML, Gaskin F, Cantor CR. Microtule assembly in the absence of added nucleotides. Proc Natl Acad Sci U S A. 1973;70:765–8.PubMed CentralView ArticlePubMedGoogle Scholar
- Dráber P, Dráberová E, Viklický V. Immunostaining of human spermatozoa with tubulin domain-specific monoclonal antibodies. Recognition of a unique beta- tubulin epitope in the sperm head. Histochemistry. 1991;95:319–24.View ArticleGoogle Scholar
- Laemmli UK. Cleavage of structural proteins during assembly of bacteriofage T4. Nature. 1970;227:680–5.View ArticlePubMedGoogle Scholar
- Towbin H, Staehelin T, Gordon G. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979;76:4350–4.PubMed CentralView ArticlePubMedGoogle Scholar
- Glander HJ, Schaller J, Rohwedder A, Henkel R. Adhesion molecules and matrix proteins on human spermatozoa. Andrologia. 1998;30(4-5):289–96.View ArticlePubMedGoogle Scholar
- Wennemuth G, Schiemann PJ, Krause W, Gressner AM, Aumuller G. Influence of fibronectin on the motility of human spermatozoa. Int J Androl. 1997;20(1):10–6.View ArticlePubMedGoogle Scholar
- Diaz ES, Kong M, Morales P. Effect of fibronectin on proteasome activity, acrosome reaction, tyrosine phosphorylation and intracellular calcium concentrations of human sperm. Hum Reprod. 2007;22(5):1420–30.View ArticlePubMedGoogle Scholar
- Thys M, Nauwynck H, Maes D, Hoogewijs M, Vercauteren D, Rijsselaere T, et al. Expression and putative function of fibronectin and its receptor (integrin alpha(5)beta(1) in male and female gametes during bovine fertilization in vitro. Reproduction. 2009;138(3):471–82.View ArticlePubMedGoogle Scholar
- Wennemuth G, Meinhardt A, Mallidis C, Albrecht M, Krause W, Renneberg H, et al. Assessment of fibronectin as a potencial new clinical tool in andrology. Andrologia. 2001;33(1):43.View ArticlePubMedGoogle Scholar
- Attia AM, Hassan A, Zalata A, Hagag M, Yousef KE, Mostala T. Seminal fibronectin In fertile and infertile males. Andrologia. 2011;43(6):387–91.View ArticlePubMedGoogle Scholar
- Eddy EM, O’Brian DA. The spermatozoon. In: Knobil E, Neil JD, editors. The physiology of reproduction. New York: Raven; 1994.Google Scholar
- Virtanen I, Badley RA, Paasivuo R, Lehto VP. Distinct cytoskeletal domains revealed in sperm cells. J Cell Biol. 1984;99:1083–91.View ArticlePubMedGoogle Scholar
- Peknicova J, Pexiderova M, Kubatova A, Koubek P, Tepla O, Sulimenko T, et al. Expression of beta-tubulin epitope in human with pathological spermiogram. Fertil Steril. 2007;88(2):1120–8.View ArticlePubMedGoogle Scholar
- Dai RM, Li CC. Valosin-containing protein is a multi-ubiquitin chain-targeting factor required in ubiquitin-proteasome degradation. Nat Cell Biol. 2001;3:740–4.View ArticlePubMedGoogle Scholar
- Geussova G, Kalab P, Peknicova J. Valosine containing protein is a substrate of cAMP-activated boar sperm tyrosine kinase. Mol Reprod Dev. 2002;63:366–75.View ArticlePubMedGoogle Scholar
- Ficarro S, Chertihin O, Westbrook A, White F, Jayes F, Kalab P, et al. Phosphoproteome analysis of capacitated human sperm. Evidence of tyrosine phosphorylation of a kinase-anchoring protein 3 and valosin-containing protein/p97 during capacitation. J Biol Chem. 2003;278(13):11579–89.View ArticlePubMedGoogle Scholar
- Vigodner M, Shrivastava V, Gutstein LE, Schneider J, Nieves E, Goldstein M, et al. Localization and identification of sumoylated proteins in human sperm: excessive sumoylation is a marker of defective spermatozoa. Hum Reprod. 2013;28(1):210–23.PubMed CentralView ArticlePubMedGoogle Scholar